According to the United States National Institutes of Health, National Human Genome Research Institute, in 2017, most of the rare diseases were genetic in nature. NGS has been considered the most potent tool in diagnostics and in researches to understand the treatment regimen for various diseases, including cancer, infectious diseases, cardiovascular diseases, etc. The introduction of such products and the technologies behind them provides an immediate competitive edge to players as a result, prominent companies are increasingly focusing on the research and development of such products to strengthen their market positions and shares.
The advancements in NGS platforms will drive the market growthĬontinuous technological innovations in sequencers have enabled the introduction of efficient, portable, and easy-to-use NGS platforms, capable of providing rapid and accurate results and boasting improved turnaround times. The global Next-Generation Sequencing (NGS) market growth is driven by the increase in genome mapping programs, rise in applications of next generation sequencing, increase in healthcare expenditure and technological advancements in sequencing platforms.
DNA pre-sequencing is one of the most significant steps in the overall sequencing protocol as it involves preparation of sample for the subsequent sequencing reaction. The low cost, high accuracy and speed, and precise results even from low sample inputs are the main advantages NGS offers over Sanger’s sequencing method. Next-Generation Sequencing (NGS) is a technology in which millions of DNA strands can be sequenced through massive parallelization, this technique is also known as high throughput sequencing. The Global Next-Generation Sequencing (NGS) Market size was valued US$ XX million in 2019 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX% during the forecast period (2021-2028). Global Next-Generation Sequencing (NGS) Market - 2021-2028
0 kommentar(er)
